The importance of the values attached to cells for a good informed consent procedure in cell donation for tissue engineering purposes

Cell and Tissue Banking

Volumn 10, Issue 4, 2009, Pages 293-299

  Trommelmans, Leen ^a   Selling, Joseph ^a   Dierickx, Kris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Donation; Ethics; Informed consent; Regenerative medicine; Tissue engineering; Value

Indexed keywords

ARTICLE; BIOCOMPATIBILITY; CELL DONATION; CELL TRANSFER; DECISION MAKING; DONOR; HEREDITY; HUMAN; IMMUNE RESPONSE; INFORMED CONSENT; MEDICAL ETHICS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

HUMANS; REGENERATIVE MEDICINE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TISSUE ENGINEERING;

EID: 70349862170     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-009-9123-6     Document Type: Article

References (34)

1. Alta Charo R (2006) Body of reserach-ownership and use of human tissue. N Engl J Med 335(15):1517-1519. doi: 10.1056/NEJMp068192
2. Andrews L, Nelkin D (2001) Body Bazaar. The market for human tissue in the biotechnology age. Crown publishers, New York
3. Balharry D, Sexton K, BeruBe K (2008) An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane. Toxicology 244(1):66-76. doi: 10.1016/ j.tox.2007.11.001
4. Björkman B (2006) Why we are not allowed to sell that which we are encouraged to donate. Camb Q Healthc Ethics 15:60-70. doi: 10.1017/ S0963180106060075
5. Bok H, Schill K, Faden R (2004) Justice, ethnicity, and stem-cell banks. Lancet 364(9429):118-121. doi: 10.1016/S0140-6736(04)16650-6
6. Cosh E, Girling A, Lilford R et al (2007) Investing in new medical technologies: A decision framework. J Commer Biotechnol 13:263-271. doi: 10.1057/palgrave.jcb.3050062
7. Council of Europe (2002) Additional protocol to the convention on human rights and biomedicine, on transplantation of organs and tissues of human origin. Strasbourg. Report No.: ETS No. 186. Available at http://conventions.coe.int/Treaty/EN/Treaties/Html/186.htm. Accessed 13 Sept 2008
8. De Bari C, Dell'Accio F, Karystinou A et al (2008) A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58(1):240-250. doi: 10.1002/art.23143
9. Dickenson D (2007) Property in the body: Feminist perspectives. Cambridge University Press, Cambridge
10. Eriksson S, Helgesson G (2005) Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur J Hum Genet 13(9):1071-1076. doi: 10.1038/sj.ejhg.5201458
11. Faden R, Dawson L, Bateman-House A et al (2003) Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Cent Rep 33:13-27. doi: 10.2307/3527822
12. Fodor W (2003) Tissue engineering and cell based therapies, from the bench to the clinic: The potential to replace, repair and regenerate. Reprod Biol Endocrinol 1:102. doi: 10.1186/1477-7827-1-102
13. Gardner R (2007) Stem cells and regenerative medicine: Principles, prospects and problems. C R Biol 330(6-7):465-473. doi: 10.1016/ j.crvi.2007.01.005
14. Griffith L, Swartz M (2006) Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7(3):211-224. doi: 10.1038/nrm1858
15. Guillot PV, Cui W, Fisk NM, Polak DJ (2007) Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med 11(5):935-944. doi: 10.1111/j.1582-4934.2007.00106.x
16. Howard D, Meltzer D, Kollman C et al (2008) Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Med Decis Making 28:243-253. doi: 10.1177/0272989X07308750
17. Kirkpatrick J, Fuchs S, Iris H et al (2007) Cell culture models of higher complexity in tissue engineering and regenerative medicine. Biomaterials 28(34):5193-5198. doi: 10.1016/j.biomaterials.2007.08.012
18. Krampera M, Pizzolo G, Aprili G, Franchini M (2006) Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39(4):678-683. doi: 10.1016/j.bone.2006.04.020
19. Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group (IWG) (2007) Advancing tissue science and engineering. A foundation for the future. A multi-agency strategic plan, 52pp
20. Nelkin D, Andrews L (1998) Homo economicus: Commercialization of body tissue in the age of biotechnology. Hastings Cent Rep 28(5):30-39. doi: 10.2307/3528230
21. Nerem RM (2007) Cell-based therapies: From basic biology to replacement, repair, and regeneration. Biomaterials 28(34):5074-5077. doi: 10.1016/ j.biomaterials.2007.07.032
22. Parenteau N (1999) Skin: The first tissue-engineered products. Sci Am 280:83-84
23. Poumay Y, Coquette A (2007) Modelling the human epidermis in vitro: tools for basic and applied research. Arch Dermatol Res 298(8):361-369. doi: 10.1007/s00403-006-0709-6
24. Schroeder D (2007) Benefit-sharing: It's time for a definition. J Med Ethics 33:205-209. doi: 10.1136/jme.2006.016790
25. Schulz-Baldes A, Biller-Andorno N, Capron A (2007) International perspectives on the ethics and regulation of human cell and tissue transplantation. Bull World Health Organ 85(12):941-948. doi: 10.2471/ BLT.06.038703
26. The European Parliament and the Council (2004) Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells, Directive 2004/23/EC, European Parliament and Council, (2004). Available via http://eur-lex.europa.eu/smartapi/cgi/ sga_doc?smartapi!celexapi!prod!CELEXnumdoc&lg=en&numdoc= 32004L0023&model=guichett. Accessed 13 September 2008
27. The European Parliament and the Council (2007) Regulation (EC) No 1394/ 2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance), (EC) No 1394/ 2007. Availablie via: http://ec.europa.eu/enterprise/pharmaceuticals/ eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf. Accessed 13 September 2008
28. Titmuss R (1971) The gift relationship: From human blood to social policy. George Allen and Unwin, London
29. Trommelmans L, Selling J, Dierickx K (2007) Ethical issues in tissue engineering, European ethical-legal papers no. 7. Centre for biomedical ethics and law, Leuven. Available at www.cbmer.be. Accessed 13 Sept 2008
30. Wadman M (2008) Blood transfusion for stem cell company? Naturenews. Available via http://www.nature.com/news/2008/220808/full/ news.2008.1060.html. Accessed 13 September 2008
31. Waldby C, Mitchell R (2006) Tissue economies. Blood, organs and cell lines in late capitalism. Duke University Press, Durham
32. Wendler D, Grady C (2008) What should research participants understand to understand they are participants in research? Bioethics 22(4):203-208. doi: 10.1111/j.1467-8519.2008.00632.x
33. Wilkinson S (2005) Biomedical research and the commercial exploitation of human tissue. Genomics Soc Policy 1(1):27-40
34. Williams DF (2006) Tissue engineering: The multidisciplinary epitome of hope and despair. In: Paton R, McNamara L (eds) Studies in multidisciplinarity, vol 3. Elsevier, Amsterdam, pp 483-524